Jose G. Montoya, MD
Infectious Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Montoya’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A48635 · Current
Licensed to practise in California · since 1990 · expires 2028-09-30 · University of the Valley Division of Health Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$7,317
Pharmacies billed $7,317 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
66 generic and fewer than 11 brand-name prescriptions · $7,317 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rabeprazole | 12 | $452 | $38 |
Year by year
| 2024 | 78 | None | None | None | $7,317 |
| 2023 | 85 | None | 0% (0) | None | $24,759 |
| 2022 | 70 | 14 | 0% (0) | None | $18,410 |
| 2021 | 44 | None | 0% (0) | None | $12,651 |
| 2020 | 65 | 15 | 0% (0) | 20% | $60,940 |
| 2019 | 247 | 46 | 0% (0) | 11% | $199,762 |
| 2018 | 399 | 77 | None | None | $235,693 |
| 2017 | 349 | 69 | None | 23% | $284,516 |
| 2016 | 299 | 66 | 0% (0) | 20% | $211,386 |
| 2015 | 393 | 87 | None | 24% | $178,571 |
| 2014 | 302 | 57 | None | 25% | $187,339 |
| 2013 | 285 | 55 | 0% (0) | 41% | $222,743 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Valganciclovir | 11 | $17,387 | $1,581 |
| Valacyclovir | 19 | $506 | $27 |
2022: 2 drugs
| Celecoxib | 25 | $2,215 | $89 |
| Valacyclovir | 12 | $1,905 | $159 |
2019: 6 drugs
| Noxafil | 18 | $112,820 | $6,268 |
| Valganciclovir | 41 | $41,063 | $1,002 |
| Famciclovir | 34 | $3,496 | $103 |
| Valacyclovir | 47 | $2,073 | $44 |
| Azithromycin | 13 | $563 | $43 |
| Acyclovir | 21 | $331 | $16 |
2018: 12 drugs
| Noxafil | 15 | $88,778 | $5,919 |
| Daptomycin | 17 | $52,474 | $3,087 |
| Valganciclovir | 48 | $38,035 | $792 |
| Atovaquone | 12 | $16,240 | $1,353 |
| Famciclovir | 49 | $8,493 | $173 |
| Valacyclovir | 26 | $1,958 | $75 |
| Cefazolin | 17 | $1,307 | $77 |
| Acyclovir | 24 | $890 | $37 |
| Clarithromycin | 16 | $874 | $55 |
| Isoniazid | 11 | $94 | $9 |
| Sulfamethoxazole-Trimethoprim | 14 | $87 | $6 |
| Pantoprazole | 14 | $66 | $5 |
2017: 9 drugs
| Valganciclovir | 62 | $116,425 | $1,878 |
| Noxafil | 16 | $87,613 | $5,476 |
| Atovaquone | 13 | $10,332 | $795 |
| Famciclovir | 51 | $7,699 | $151 |
| Hydroxychloroquine Sulfate | 20 | $2,859 | $143 |
| Clarithromycin | 14 | $664 | $47 |
| Acyclovir | 24 | $448 | $19 |
| Pantoprazole | 16 | $96 | $6 |
| Sulfamethoxazole-Trimethoprim | 16 | $93 | $6 |
2016: 8 drugs
| Valganciclovir | 52 | $89,247 | $1,716 |
| Noxafil | 16 | $75,556 | $4,722 |
| Famciclovir | 43 | $6,883 | $160 |
| Hydroxychloroquine Sulfate | 23 | $2,968 | $129 |
| Fluconazole | 11 | $2,009 | $183 |
| Valacyclovir | 24 | $1,485 | $62 |
| Clarithromycin | 11 | $1,415 | $129 |
| Acyclovir | 22 | $925 | $42 |
2015: 9 drugs
| Valcyte | 16 | $68,046 | $4,253 |
| Valganciclovir | 21 | $49,682 | $2,366 |
| Famciclovir | 48 | $6,743 | $140 |
| Colchicine | 19 | $5,805 | $306 |
| Valacyclovir | 73 | $5,079 | $70 |
| Colcrys | 17 | $4,836 | $284 |
| Hydroxychloroquine Sulfate | 20 | $2,411 | $121 |
| Acyclovir | 41 | $925 | $23 |
| Sulfamethoxazole-Trimethoprim | 11 | $116 | $11 |
2014: 8 drugs
| Valcyte | 23 | $101,910 | $4,431 |
| Sporanox | 11 | $18,671 | $1,697 |
| Colcrys | 28 | $8,209 | $293 |
| Famciclovir | 38 | $6,269 | $165 |
| Clarithromycin | 11 | $1,060 | $96 |
| Acyclovir | 56 | $1,002 | $18 |
| Hydroxychloroquine Sulfate | 15 | $349 | $23 |
| Sulfamethoxazole-Trimethoprim | 21 | $158 | $8 |
2013: 12 drugs
| Valcyte | 29 | $96,536 | $3,329 |
| Noxafil | 14 | $64,684 | $4,620 |
| Itraconazole | 23 | $15,806 | $687 |
| Sporanox | 12 | $6,459 | $538 |
| Colcrys | 27 | $5,954 | $221 |
| Famciclovir | 20 | $4,745 | $237 |
| Valacyclovir | 22 | $3,329 | $151 |
| Clarithromycin | 15 | $2,848 | $190 |
| Acyclovir | 29 | $1,358 | $47 |
| Levofloxacin | 15 | $534 | $36 |
| Sulfamethoxazole-Trimethoprim | 20 | $120 | $6 |
| Azithromycin | 12 | $113 | $9 |
Money from drug and device companies
$20 in 2024
| 2024 | 1 | 1 | None | $20 |
| 2023 | 2 | 3 | None | $205 |
| 2020 | 1 | 1 | $2,075 | $2,075 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Thinprep 2000 Processor | $20 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2024-05-14 | Thinprep 2000 Processor | $20 |
See earlier years (2023, 2020)
2023: $205
| E.R. Squibb & Sons L.L.C. | None | $125 | 1 payment
|
| Melinta Therapeutics | Rezzayo | $80 | 2 payments
|
2020: $2,075
| Medicines360 | Liletta | $2,075 | 1 payment
|
Professional record
- NPI
- 1649306804
- Licence
- CA A48635California A48635: Current · expires 2028-09-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A486350
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 2680 Hanover St, Palo Alto, CA, 94304
- NPI first listed
- 2007-02-24
- NPI last updated
- 2009-05-21
This is when the NPI record was last certified, not a medical board exam.